Laura Testa

3.0k total citations · 1 hit paper
59 papers, 977 citations indexed

About

Laura Testa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Laura Testa has authored 59 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Laura Testa's work include Advanced Breast Cancer Therapies (18 papers), Cancer Treatment and Pharmacology (14 papers) and Breast Cancer Treatment Studies (13 papers). Laura Testa is often cited by papers focused on Advanced Breast Cancer Therapies (18 papers), Cancer Treatment and Pharmacology (14 papers) and Breast Cancer Treatment Studies (13 papers). Laura Testa collaborates with scholars based in Brazil, United States and Spain. Laura Testa's co-authors include Vassiliki Karantza, Anthony Gonçalvès, Javier Cortés, Nadia Harbeck, Peter Schmid, Stefania Zambelli, Fabrice André, Seock‐Ah Im, Eric P. Winer and Shoichiro Ohtani and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Laura Testa

51 papers receiving 958 citations

Hit Papers

Pembrolizumab versus investigator-choice chemotherapy for... 2021 2026 2022 2024 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
    2021 330 citations Eric P. Winer, Seock‐Ah Im et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Testa Brazil 13 748 244 204 190 103 59 977
Katsuya Suzuki Japan 9 456 0.6× 205 0.8× 37 0.2× 158 0.8× 98 1.0× 18 736
Martina Jänicke Germany 16 333 0.4× 228 0.9× 165 0.8× 37 0.2× 280 2.7× 49 758
Weiqing Zhao China 15 282 0.4× 210 0.9× 130 0.6× 112 0.6× 215 2.1× 46 641
Ilona Urbárová Norway 9 235 0.3× 69 0.3× 73 0.4× 79 0.4× 103 1.0× 18 523
Raffaele Conca Italy 12 233 0.3× 116 0.5× 72 0.4× 116 0.6× 106 1.0× 54 533
Chaitanya R. Acharya United States 17 702 0.9× 160 0.7× 555 2.7× 195 1.0× 449 4.4× 42 1.8k
Stéphanie Hoppe France 10 234 0.3× 130 0.5× 97 0.5× 109 0.6× 232 2.3× 19 696
Claudio Martín Argentina 13 461 0.6× 466 1.9× 152 0.7× 105 0.6× 207 2.0× 58 786
Jiarui Yao China 12 277 0.4× 130 0.5× 103 0.5× 196 1.0× 323 3.1× 55 767
C. Arnold Austria 12 162 0.2× 121 0.5× 137 0.7× 150 0.8× 172 1.7× 25 651

Countries citing papers authored by Laura Testa

Since Specialization
Citations

This map shows the geographic impact of Laura Testa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Testa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Testa more than expected).

Fields of papers citing papers by Laura Testa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Testa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Testa. The network helps show where Laura Testa may publish in the future.

Co-authorship network of co-authors of Laura Testa

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Testa. A scholar is included among the top collaborators of Laura Testa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Testa. Laura Testa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bardia, Aditya, Lajos Pusztai, Kathy S. Albain, et al.. (2024). TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy. Therapeutic Advances in Medical Oncology. 16. 12693072–12693072. 16 indexed citations
3.
4.
Bonadio, Renata Colombo, et al.. (2024). Visceral crisis in metastatic breast cancer: an old concept with new perspectives. Clinics. 79. 100362–100362.
5.
Goetz, Matthew P., İrfan Çiçin, Laura Testa, et al.. (2024). Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. npj Breast Cancer. 10(1). 34–34. 12 indexed citations
6.
Wang, Ming, Laura Testa, Renata Colombo Bonadio, et al.. (2024). Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor–Positive Advanced Breast Cancer. JCO Oncology Practice. 21(6). 832–842. 2 indexed citations
7.
8.
Petry, Vanessa, et al.. (2024). Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique. International Journal of Radiation Oncology*Biology*Physics. 119(4). 1086–1091. 4 indexed citations
9.
O’Shaughnessy, Joyce, Laura Testa, Sara M. Tolaney, et al.. (2023). 274P Impact of dose reductions on efficacy of adjuvant abemaciclib for patients with high-risk early breast cancer (EBC): Analyses from the monarchE study. Annals of Oncology. 34. S293–S293. 1 indexed citations
10.
Petry, Vanessa, et al.. (2023). A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53). The Breast. 68. 157–162. 2 indexed citations
11.
Petry, Vanessa, et al.. (2023). Abstract P1-03-05: Overview of the management and factors associated with outcomes of metastatic breast cancer among elderly patients. Cancer Research. 83(5_Supplement). P1–3. 1 indexed citations
12.
Bonadio, Renata Colombo, et al.. (2022). Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast Cancer. Clinical Breast Cancer. 22(8). e892–e900. 3 indexed citations
13.
Bonadio, Renata Colombo, et al.. (2022). 179P Does undertreatment of elderly patients with early breast cancer impact outcome?. Annals of Oncology. 33. S619–S619.
14.
Testa, Laura, Max S. Mano, Renata Colombo Bonadio, et al.. (2021). Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy. Clinics. 76. e3146–e3146. 3 indexed citations
15.
16.
Costa, Isabela Bispo Santos da Silva, Cristina Salvadori Bittar, Stéphanie Itala Rizk, et al.. (2020). Câncer e Doenças Cardiovasculares na Pandemia de COVID-19/ Cancer and Cardiovascular Diseases during the COVID-19 Pandemic. Arquivos Brasileiros de Cardiologia. 115(3). 1 indexed citations
17.
Costa, Isabela Bispo Santos da Silva, Cristina Salvadori Bittar, Stéphanie Itala Rizk, et al.. (2020). Câncer e Doenças Cardiovasculares na Pandemia de COVID-19. Arquivos Brasileiros de Cardiologia. 115(3). 547–557. 5 indexed citations
18.
Im, S-A., Javier Cortés, Oleg Lipatov, et al.. (2020). 44O Pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-119 Asia-Pacific subpopulation. Annals of Oncology. 31. S1258–S1258. 4 indexed citations
19.
Hepner, Adriana, Pedro Exman, Laura Testa, et al.. (2019). Cancer During Pregnancy: The Oncologist Overview. World Journal of Oncology. 10(1). 28–34. 77 indexed citations
20.
Selbmann, Laura, Eleonora Egidi, Daniela Isola, et al.. (2012). Biodiversity, evolution and adaptation of fungi in extreme environments. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. 147(1). 237–246. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuya Suzuki Breakdown of academic impact, for papers by Martina Jänicke Breakdown of academic impact, for papers by Weiqing Zhao Breakdown of academic impact, for papers by Ilona Urbárová Breakdown of academic impact, for papers by Raffaele Conca Breakdown of academic impact, for papers by Chaitanya R. Acharya Breakdown of academic impact, for papers by Stéphanie Hoppe Breakdown of academic impact, for papers by Claudio Martín Breakdown of academic impact, for papers by Jiarui Yao Breakdown of academic impact, for papers by C. Arnold
Rankless by CCL
2026